Volume 28, Issue 1 supplement | BioDrugs

Home
BioDrugs
Volumes and issues
Volume 28, Issue 1 supplement

BioDrugs

Publishing model:: Hybrid

Submit your manuscript

Search all BioDrugs articles

Volume 28, Issue 1 supplement

April 2014

Optimisation of TNF-Inhibitor Therapy for Rheumatoid Arthritis: Focus on Certolizumab Pegol

Filter by

Volume:

Sort by

Date published:

New to old Old to new

5 articles in this issue

Optimisation of TNF-Inhibitor Therapy for Rheumatoid Arthritis: Focus on Certolizumab Pegol

Events 01 April 2014 Pages: 1 - 1
How FABulous is PEGgy? Certoliziumab Pegol from the Bench to the Patients
Daniel Aletaha
Foreword 01 April 2014 Pages: 3 - 4
Tumour Necrosis Factor α Antagonists in the Treatment of Rheumatoid Arthritis: An Immunological Perspective
Pier-Luigi Meroni
Guido Valesini
Review Article 01 April 2014 Pages: 5 - 13
Pegylation of Biological Molecules and Potential Benefits: Pharmacological Properties of Certolizumab Pegol
Gianfranco Pasut
Review Article 01 April 2014 Pages: 15 - 23
Efficacy and Safety of Certolizumab Pegol in Rheumatoid Arthritis: Meeting Rheumatologists’ Requirements in Routine Clinical Practice
Leonardo Punzi
Giovanni Lapadula
Alessandro Mathieu
Review Article 01 April 2014 Pages: 25 - 37